Nemours Alfred I duPont Hospital for Children — Wilmington, Delaware

Nemours Alfred I duPont Hospital for Children is a clinical research site located in Wilmington, Delaware, United States 19803.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Nemours Alfred I duPont Hospital for Children has participated in 62 clinical trials with 17 currently active.

Therapeutic areas: Recurrent and Refractory Solid Tumors, Biliary Atresia, Achondroplasia.

Sponsors: Eisai Inc., Albireo, an Ipsen Company, QED Therapeutics, a BridgeBio company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in Delaware · View every site in Wilmington

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nemours Alfred I duPont Hospital for Children?

Nemours Alfred I duPont Hospital for Children has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nemours Alfred I duPont Hospital for Children conducted?

Nemours Alfred I duPont Hospital for Children has 62 clinical trials on record, with 17 currently active. Their work covers Recurrent and Refractory Solid Tumors, Biliary Atresia, Achondroplasia.

Is Nemours Alfred I duPont Hospital for Children accredited by Crixeo Clinical Trials?

Nemours Alfred I duPont Hospital for Children has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nemours Alfred I duPont Hospital for Children?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.